← Health care and life sciences companies

    A2 Biotherapeutics: company profile, size and contacts

    a2bio.comActiveFor profit

    A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.

    Employees
    51-100
    Founded
    2018
    Total raised
    $190.5M
    Region
    Greater Los Angeles Area

    Company facts

    Website
    a2bio.com
    Location
    Greater Los Angeles Area, West Coast, Western US
    Employees
    51-100
    Founded
    2018 (8 years ago)
    Categories
    Biotechnology, Health Care, Life Science
    Company type
    For profit
    Listing
    Private
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Alexander KambFounder · A2 Biotherapeutics

    A2 Biotherapeutics was founded in 2018 by Alexander Kamb.

    Funding

    Total raised
    $190.5M
    Funding rounds
    4
    Latest round
    Series B, 2022-12
    Investors
    8

    How A2 Biotherapeutics compares

    • Size: A2 Biotherapeutics has more employees than 56% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: A2 Biotherapeutics is older than 8% of the 1166 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 159 of them in the same 51-100 employee range and 48 based in Greater Los Angeles Area.

    Growth outlook

    • Trend: Growing

    A2 Biotherapeutics may be growing as indicated by the company's active participation in the American Society of Clinical Oncology (ASCO) Annual Meeting, where they highlighted the progress of their CAR T clinical programs through three poster presentations. This suggests ongoing research and development efforts, which are critical for growth in the biotechnology industry. Additionally, the mention of a C-Suite shuffle implies organizational changes that could be associated with expansion or scaling efforts. The focus on CAR T-cell clinical programs also indicates a specialization in a cutting-edge area of biotechnology, which could position the company for growth within the health care and life science industries.

    What A2 Biotherapeutics says about itself

    “A2 is dedicated to advancing cancer treatment through pioneering cell therapy. Our T cells target solid tumors with precision, transforming the future of medicine.” a2bio.com

    A2 Biotherapeutics in short

    A2 Biotherapeutics is a biotechnology company based in Greater Los Angeles Area, with 51-100 employees, founded in 2018. Its founder is Alexander Kamb and it has raised $190.5 million over 4 rounds.

    Frequently asked questions

    What does A2 Biotherapeutics do?
    A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.
    When was A2 Biotherapeutics founded?
    A2 Biotherapeutics was founded in 2018, so it is about 8 years old.
    How many employees does A2 Biotherapeutics have?
    Crunchbase lists A2 Biotherapeutics in the 51-100 employee range.
    Where is A2 Biotherapeutics based?
    A2 Biotherapeutics is listed under Greater Los Angeles Area, West Coast, Western US.
    Has A2 Biotherapeutics raised funding?
    Crunchbase records $190.5M raised across 4 funding rounds, most recently series b in 2022-12.
    How do I find email addresses at A2 Biotherapeutics?
    Search the domain a2bio.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.